Where does Feellife Health Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Feellife Health Inc. ranks #26,289 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Feellife Health Inc. hold?

Feellife Health Inc. holds 10 US utility patents granted between 2023 and 2025, spanning 3 technology areas.

What is Feellife Health Inc.'s Innovation Score?

Feellife Health Inc. has an Innovation Score of 36.3 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Feellife Health Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Feellife Health Inc..

What does claim depth mean for Feellife Health Inc.'s patents?

Feellife Health Inc.'s patents average 3.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Feellife Health Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Feellife Health Inc.

Q: What technology areas does Feellife Health Inc. focus on?

Feellife Health Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 3 patents, ranking #1,777 of 3,490 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 3 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Feellife ranks #26,289 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 3 technology areas.

#26,289
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.3/100): 3.2
avg claims per patent

USPTO PatentsView assignee plate

Corpus R26289 · Foreign Corporation #26,289 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 10 grants
MID-PACK #26,289/49,997
PHOTO-FINISH Factory Five Licensing
CPC-NARROW A61M · 3 areas
INNOV-THIN 36.3/100
CLAIMS-SPARSE 3.2 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Factory Five Licensing, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Feellife’s 36.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (23%) Velocity 20.0 pts (55%) Breadth 6.1 pts (17%) Claim depth 1.9 pts (5%)

Qualcomm Incorporated · highest

85
Feellife Health · this assignee

36
3D Lighting… · lowest

7

What this shows Feellife's Innovation Score is 36.3/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Feellife?

Each dot is one of Feellife’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Feellife’s own 3.2 claims/patent is at or below the 13.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Feellife vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Feellife's grants concentrate

Feellife Health Inc. is a focused PatentsView assignee: 3 CPC subclasses with 30% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2024 (6 grants) versus a trough of 2 in 2023. By volume, Feellife sits between Fuso Chemical Co., Ltd. and Firstbeat Analytics Oy.

Feellife's three-year grant acceleration

Feellife Health Inc. shows 8 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Fuso Chemical

10
Futureplay

10
Factory Five Lice…

10
Federal Lock

10
Fend Incorporated

10
Finnovate Group

10
First Ammonia Mot…

10
Firstbeat Analyti…

10
Feellife Health ◀

10

What this shows Feellife holds 10 patents at rank #26,316, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Feellife

By rank, the assignees closest to #26,316 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Feellife's primary technology class.

Feellife's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Feellife Health Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	2	20.0%
2024	6	60.0%
2025partial year	2	20.0%

Which technologies does Feellife Health Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 2

A24F - Smokers' REQUISITES; Match BOXES; Simulated Smoking Devices 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Feellife Health Inc.'s patent record in context - here's where to go next.

Feellife Health Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 30% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #26,289 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Feellife Health Inc. against Fuso Chemical Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.